UPDATE: Potential Risks with Liquid-filled Intragastric Balloons - Letter to Health Care Providers
Date of publication: 27-04-2020
An update on the potential risks of over-inflation (spontaneous hyperinflation), acute pancreatitis, and deaths in patients with Orbera and ReShape liquid-filled intragastric balloons used for weight loss in adult patients with obesity. Źródło: http://www.fda.gov
